Published in Postgrad Med J on February 01, 1971
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet (1977) 8.77
Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med (1966) 5.80
Tempting fate: control of communicable disease in England. BMJ (1993) 5.62
Application of microtitration techniques to bacteriostatic and bactericidal antibiotic susceptibility testing. J Lab Clin Med (1968) 5.46
Field Evaluation of a Human Anthrax Vaccine. Am J Public Health Nations Health (1962) 5.44
Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann Intern Med (1969) 4.41
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol (1982) 4.35
Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44
Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J Clin Microbiol (1983) 2.97
Influenza and bacterial pneumonia. Int J Antimicrob Agents (2009) 2.69
Amoxycillin--pharmacology, bacteriology and clinical studies. Br J Clin Pract (1972) 2.65
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet (1980) 2.55
Laboratory and clinical evaluation of carbenicillin (carboxybenzyl penicillin). Antimicrob Agents Chemother (Bethesda) (1968) 2.51
Spectinomycin and penicillin G in the treatment of gonorrhea. A comparative evaluation. JAMA (1972) 2.30
Clinical and bacteriological studies with clindamycin. Br Med J (1970) 2.21
Significance of bacterial variants in urine of patients with chronic bacteriuria. J Clin Invest (1965) 2.18
Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) (1966) 1.99
Meningococcal meningitis or septicaemia: a plea for diagnostic clarity. Lancet (1992) 1.96
Bacterial endocarditis in England in the 1970's: a review of 70 patients. Q J Med (1977) 1.95
Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model. J Infect Dis (1976) 1.95
Advertising of antibiotics. Br Med J (1973) 1.86
Ceftazidime--a new extended-spectrum cephalosporin. Lancet (1982) 1.79
In vitro evaluation of cefoxitin and cefamandole. Antimicrob Agents Chemother (1976) 1.78
Sporadic non A non B hepatitis in Birmingham. J Infect (1981) 1.76
Treatment of the acute urethral syndrome. N Engl J Med (1981) 1.71
Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin. J Infect Dis (1977) 1.70
Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med (1989) 1.67
Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun (1981) 1.66
Mycoplasma hominis and abortion. J Infect Dis (1970) 1.64
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med (1980) 1.61
Infections acquired by hospitalized patients. An analysis of the overall problem. Arch Intern Med (1968) 1.61
Ampicillin in the treatment of enterococcal endocarditis. Ann Intern Med (1966) 1.58
Evaluation of an indanyl ester of carbenicillin. Antimicrob Agents Chemother (Bethesda) (1970) 1.58
Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med (1986) 1.57
Single-dose aqueous procaine penicillin G therapy for gonorrhea: use of probenecid and cause of treatment failure. J Infect Dis (1973) 1.54
Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol (1973) 1.52
Evaluation of a new cephalosporin antibiotic, cephapirin. Antimicrob Agents Chemother (1972) 1.50
Studies on the epidemiology of Escherichia coli infections. V. Factors influencing acquisition of specific serologic groups. J Clin Invest (1967) 1.48
Risk of AIDS to health care workers. Br Med J (Clin Res Ed) (1986) 1.43
Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of recurrence in chronic bacteriuria. N Engl J Med (1968) 1.40
In vitro evaluation of a new quinolone antibacterial. Antimicrob Agents Chemother (1975) 1.38
Bacterial meningitis--ten years experience. J Hyg (Lond) (1982) 1.37
Nephrotoxicity due to cephaloridine: a light- and electron-microscopic study in rabbits. J Infect Dis (1970) 1.35
Recovery of Neisseria gonorrhoeae from "Sterile" synovial fluid in gonococcal arthritis. N Engl J Med (1971) 1.35
New cephalosporin antibiotic--cephaloridine. Clinical and laboratory evaluation. Arch Intern Med (1967) 1.34
Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole. Rev Infect Dis (1982) 1.33
Protection against pertussis by immunisation. Br Med J (1980) 1.33
Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas. Antimicrob Agents Chemother (1973) 1.31
Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med (1977) 1.31
Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide. Antimicrob Agents Chemother (1979) 1.30
The relationship of infection and DNA-synthesizing cells in human blood. J Lab Clin Med (1967) 1.30
Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis (1971) 1.29
Serratia marcescens in a general hospital. Q J Med (1977) 1.26
Comparative therapeutic and pharmacological evaluation of amoxicillin and ampicillin plus probenecid for the treatment of gonorrhea. Antimicrob Agents Chemother (1974) 1.26
Open study of ciprofloxacin in enteric fever. J Antimicrob Chemother (1989) 1.26
Gentamicin nephrotoxicity: failure of three cephalosporins to potentiate injury in rats. Antimicrob Agents Chemother (1975) 1.24
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. J Antimicrob Chemother (1986) 1.24
Relapsing hepatitis associated with hepatitis A virus. Lancet (1982) 1.23
The use of parenteral clindamycin in the treatment of obstetric-gynecologic patients with severe infections. A comparison of a clindamycin-kanamycin combination with penicillin-kanamycin. Obstet Gynecol (1974) 1.23
Meningococcal meningitis complicated by pericarditis, panophthalmitis, and arthritis. Br Med J (1970) 1.20
Effect of bacteriuria on renal concentrating mechanisms. Ann Intern Med (1969) 1.19
Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother (1977) 1.19
Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates. J Clin Microbiol (1995) 1.18
In vitro activity of cinoxacin, an organic acid antibacterial. Antimicrob Agents Chemother (1975) 1.18
The antibiotic treatment of typhoid fever. J Antimicrob Chemother (1977) 1.17
Relapse and reinfection in chronic bacteriuria. N Engl J Med (1966) 1.17
Malaria in Birmingham and a London teaching hospital. Br Med J (1979) 1.16
Emergence of resistant organisms as a function of dose in oxolinic acid therapy. Am J Med Sci (1971) 1.15
Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol (1979) 1.13
Cefazolin in the treatment of bacterial pneumonia. J Infect Dis (1973) 1.13
Gastrointestinal side effects of clindamycin and ampicillin therapy. J Infect Dis (1977) 1.12
The role of carbenicillin in treatment of infections of the urinary tract. J Infect Dis (1970) 1.11
Effect of corticosteroids on course of Guillain-Barré syndrome. Lancet (1974) 1.11
Urinary-tract infection: localisation and virulence of Escherichia coli. Lancet (1975) 1.11
Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med (1985) 1.10
The role of penicillin-induced bacterial variants in experimental pyelonephritis. J Exp Med (1967) 1.10
67 Ga-citrate for scanning experimental staphylococcal abscesses. J Nucl Med (1973) 1.10
Treatment and follow-up studies with co-trimoxazole in enteric fever and in typhoid carriers. J Antimicrob Chemother (1975) 1.10
Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria. Lancet (1972) 1.09
Evaluation of trimethoprim-sulphamethoxazole compound in treatment of salmonella infections. Br Med J (1971) 1.09
Antibiotic synergism: enhanced susceptibility of enterococci to combinations of streptomycin and penicillins or cephalosporins. Antimicrob Agents Chemother (Bethesda) (1966) 1.08
Mycoplasma hominis septicemia associated with abortion. Am J Obstet Gynecol (1967) 1.07
Acute osteomyelitis in a district general hospital. Lancet (1982) 1.06
Malaria in Birmingham 1968-73. Br Med J (1974) 1.06
The problem of infections due to gram-negative organisms. Antimicrob Agents Chemother (Bethesda) (1966) 1.06
Patterns of oropharyngeal and fecal flora in patients with acute leukemia. J Infect Dis (1981) 1.05
Lancefield group C streptococcal endocarditis. Thorax (1974) 1.05
Amoxicillin, a new penicillin antibiotic. Antimicrob Agents Chemother (1973) 1.04
[Proposal of a standard method for clinical evaluation of antimicrobial agents in prostatitis--specifications of patients and criteria for evaluation of clinical efficacy]. Hinyokika Kiyo (1989) 1.04
Pneumococcal bacteraemia--a continuing challenge. Q J Med (1984) 1.04
Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol (1966) 1.03
Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics. Antimicrob Agents Chemother (1984) 1.02
The effect of cryotherapy on intraarticular temperature and postoperative care after anterior cruciate ligament reconstruction. Am J Sports Med (1999) 1.02
In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates. J Antimicrob Chemother (1982) 1.01
In vitro and in vivo evaluation of cephalexin. Antimicrob Agents Chemother (Bethesda) (1968) 1.01
Nosocomial infection of the urinary tract. Am J Med (1981) 1.00